Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ADMA Adma Biologics Inc

6,63

0,05 (0,76%)

Zuletzt aktualisiert: 21:00:12

Verzögert um 15 Minuten

Form 144/A - Report of proposed sale of securities: [Amend]

Adma Biologics (NASDAQ:ADMA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Adma Biologics Charts.

Adma Biologics (NASDAQ:ADMA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Adma Biologics Charts.

News Adma Biologics Inc

Form 8-K - Current report
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
Dienstag 5 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Adma Biologics Inc News-Artikel

Health Care Select Sector

JP Morgan Chase

Deutsche Telekom (QX)

Financial Select Sector

Invesco QQQ Trust Series 1

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen